Acute toxicity of three-dimensional conformal radiotherapy in prostate cancer patients eligible for implant monotherapy

International Journal of Radiation Oncology Biology Physics

Volumn 47, Issue 1, 2000, Pages 115-119

  Chou, Rachel H ^a   Wilder, Richard B ^a   Ji, Ming ^a   Ryu, Janice K ^a   Leigh, Bryan R ^a   Earle, John D ^a   Doggett, R L Scotte ^a   Kubo, H Dale ^a   Roach III, Mack ^c   Devere White, Ralph W ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Acute toxicity; Prostate cancer; Radiotherapy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ACUTE TOXICITY; ARTICLE; CANCER STAGING; CLINICAL TRIAL; DIARRHEA; GASTROINTESTINAL TOXICITY; HEMATURIA; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; NOCTURIA; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; RADIATION FIELD; SEMINAL VESICLE; TUMOR VOLUME; URINE RETENTION;

ACUTE DISEASE; BRACHYTHERAPY; DIGESTIVE SYSTEM; HUMANS; MALE; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL; RETROSPECTIVE STUDIES; URINATION DISORDERS;

EID: 17144436639     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(00)00422-3     Document Type: Article

References (31)

1. Hanks G.E., Hanlon A.L., Schultheiss T.E., et al. Dose escalation with 3D conformal treatment Five year outcomes, treatment optimization, and future directions . Int J Radiat Oncol Biol Phys. 41:1998;501-510.
2. Pollack A., Zagars G. External beam radiotherapy dose response of prostate cancer. Int J Radiat Oncol Biol Phys. 39:1997;1011-1018.
3. Pollack A., Zagars G., Starkschall G., et al. Conventional vs. conformal radiotherapy for prostate cancer Preliminary results of dosimetry and acute toxicity . Int J Radiat Oncol Biol Phys. 34:1996;555-564.
4. D'Amico A., Coleman C.N. Role of interstitial radiotherapy in the management of clinically organ-confined prostate cancer The jury is still out . J Clin Oncol. 14:1996;304-315.
5. Blasko J.C., Wallner K., Grimm P.D., et al. Prostate specific antigen based disease control following ultrasound guided iodine-125 implantation for stage T1/T2 prostatic carcinoma. J Urol. 154:1995;1096-1099.
6. Wallner K., Roy J., Harrison L. Tumor control and morbidity following transperineal iodine 125 implantation for stage T1/T2 prostate carcinoma. J Clin Oncol. 14:1996;449-453.
7. Stock R.G., Stone N.N. The effects of prognostic factors on therapeutic outcome following transperineal prostate brachytherapy. Semin Surg Oncol. 13:1997;454-460.
8. Beyer D.C., Priestly J.B. Biochemical disease free survival following I-125 prostate implantation. Int J Radiat Oncol Biol Phys. 37:1997;559-563.
9. Zelefsky M.J., Leibel S.A., Gaudin P.B., et al. Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer. Int J Radiat Oncol Biol Phys. 41:1998;491-500.
10. Fukunaga-Johnson N., Sandler H.M., McLaughlin P.W., et al. Results of 3D conformal radiotherapy in the treatment of localized prostate cancer. Int J Radiat Oncol Biol Phys. 38:1997;311-317.
11. Pound C.R., Partin A.W., Epstein J.I., et al. Prostate-specific antigen after anatomic radical prostatectomy Patterns of recurrence and cancer control . Urol Clin North Am. 24:1997;395-406.
12. Stone NN. Permanent prostate implant therapy: Recent advances in the management of prostate cancer. Proceedings of local urology meeting, Lancaster, PA. Oct. 14, 1998; p. 5-10.
13. Pickett B., Roach M., Horine P., et al. Optimization of the oblique angles in the treatment of prostate cancer during six field conformal radiotherapy. Med Dosim. 19:1994;237-254.
14. Diaz A., Roach M. III, Marquez C., et al. Indications for and the significance of seminal vesicle irradiation during 3D conformal radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys. 30:1994;323-329.
15. Sandler H.M., McLaughlin P.W., Ten Haken R.K., et al. Three dimensional conformal radiotherapy for the treatment of prostate cancer Low risk of chronic rectal morbidity observed in a large series of patients . Int J Radiat Oncol Biol Phys. 33:1995;797-801.
16. Lee W.R., Hanks G.E., Hanlon A.L., et al. Lateral rectal shielding reduces late rectal morbidity following high dose three-dimensional conformal radiation therapy for clinically localized prostate cancer Further evidence for a significant dose effect . Int J Radiat Oncol Biol Phys. 35:1996;251-257.
17. 125I prostate implantation. Int J Radiat Oncol Biol Phys. 28:1994;985-990.
18. Zelefsky M.J., Wallner K.E., Ling C.C., et al. Comparison of the 5-year outcome and morbidity of three-dimensional conformal radiotherapy versus transperineal permanent iodine-125 implantation for early-stage prostatic cancer. J Clin Oncol. 17:1999;517-522.
19. Nag S., Scaperoth D.D., Badalament R., et al. Transperineal palladium 103 prostate brachytherapy Analysis of morbidity and seed migration . Urology. 45:1995;87-92.
20. Stromberg J., Martinea A., Gonzalez J., et al. Ultrasound-guided high dose rate conformal brachytherapy boost in prostate cancer Treatment description and preliminary results of a phase I/II clinical trial . Int J Radiat Oncol Biol Phys. 1995;161-171.
21. Butler E.B., Scardino P.T., The B.S., et al. The Baylor College of Medicine experience with gold seed implantation. Semin Surg Oncol. 13:1997;406-418.
22. Gelblum D.Y., Potters L., Ashley R., et al. Urinary morbidity following ultrasound-guided transperineal prostate seed implantation. (Abstr) Int J Radiat Oncol Biol Phys. 42:(Suppl. 1):1998;220.
23. Koper P.C.M., Stroom J.C., Putten W.L.J.V., et al. Acute morbidity reduction using 3DCRT for prostate carcinoma A randomized study . Int J Radiat Oncol Biol Phys. 43:1999;727-734.
24. Tait D.M., Nahum A.E., Meyer L.C., et al. Acute toxicity in pelvic radiotherapy A randomized trial of conformal versus conventional treatment . Radiother Oncol. 42:1997;121-136.
25. Hanks G.E., Schultheiss T.E., Hunt M.A., et al. Factors influencing incidence of acute grade 2 morbidity in conformal and standard radiation treatment of prostate cancer. Int J Radiat Oncol Biol Phys. 31:1995;25-29.
26. Leibel S.A., Heimann R., Kutcher G.J., et al. Three-dimensional conformal radiation therapy in locally advanced carcinoma of the prostate Preliminary results of a phase I dose-escalation study . Int J Radiat Oncol Biol Phys. 28:1993;55-65.
27. Zelefsky M.J., Leibel S.A., Jutcher G.J., et al. The feasibility of dose escalation with three-dimensional conformal radiotherapy in patients with prostatic cancer. Cancer J Sci Am. 1:1995;142-150.
28. Vijayakumar S., Awan A., Karrison T., et al. Acute toxicity during external-beam radiotherapy for localized prostate cancer Comparison of different techniques . Int J Radiat Oncol Biol Phys. 25:1993;359-371.
29. Michalski JM, Purdy JA, Winter K; et al. Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406. Int J Radiat Oncol Biol Phys. In press.
30. Nguyen L.N., Pollack A., Zagars G.K. Late effects after radiotherapy for prostate cancer in a randomized dose-response study Results of a self-assessment questionnaire . Urology. 51:1998;991-997.
31. Dearnaley D.P., Khoo V.S., Norman A.R., et al. Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer A randomised trial . Lancet. 353:1999;267-272.